XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Oct. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Non-Cash Stock Compensation Expense

Non-cash stock compensation expense is as follows:

 

 

(in thousands)
 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

October 30,

 

 

October 31,

 

 

October 30,

 

 

October 31,

 

Type of Non-Cash Stock Compensation

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Restricted stock and restricted stock unit grants (a)

 

$

8,192

 

 

$

6,410

 

 

$

22,132

 

 

$

19,048

 

Stock option grants (a)

 

 

4,815

 

 

 

4,679

 

 

 

13,891

 

 

 

15,707

 

Performance stock unit grants (a)

 

 

4,290

 

 

 

2,317

 

 

 

17,333

 

 

 

8,696

 

Total (b)

 

$

17,297

 

 

$

13,406

 

 

$

53,356

 

 

$

43,451

 

 

(a)
Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).
The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 30, 2021, the tax benefit related to the Company’s non-cash stock compensation was approximately $3.1 million and $9.2 million, respectively. For the three and nine month periods ended October 31, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.3 million and $8.3 million, respectively.
Stock Option Transactions

Stock option transactions during the nine month period ended October 30, 2021 are summarized as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price Per
Share

 

Options outstanding, January 30, 2021

 

 

1,346,775

 

 

$

133.86

 

Options granted

 

 

209,244

 

 

 

315.81

 

Options exercised (a)

 

 

(346,436

)

 

 

91.24

 

Options forfeited

 

 

(36,961

)

 

 

192.20

 

Options outstanding, October 30, 2021

 

 

1,172,622

 

 

$

177.08

 

 

(a)
Options exercised during the nine month period ended October 30, 2021 had a total intrinsic value of $75.0 million.
Stock Options Vested and Expected to Vest

The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 30, 2021:

 

 

Options

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

Weighted
Average
Exercise
Price

 

 

Aggregate
Intrinsic
Value
(in millions)

 

Options vested and expected to vest

 

 

1,172,622

 

 

 

6.6

 

 

$

177.08

 

 

$

124.3

 

Options exercisable

 

 

570,152

 

 

 

4.9

 

 

$

136.73

 

 

$

79.6

 

Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted

The fair value of each stock option granted during the nine month period ended October 30, 2021 was estimated using the Black Scholes option pricing model using the following assumptions:

 

 

 

Nine Months Ended

 

 

 

October 30,

 

 

 

2021

Risk-free interest rate

 

 

0.45% - 1.13%

Expected volatility

 

 

34% - 35%

Expected life (years)

 

 

6.00 - 6.25

Contractual life (years)

 

 

10.0

Expected dividend yield

 

 

0.0%

Weighted average grant date fair value of options issued

 

$

110.12

Award Grant and Vesting Transactions Restricted stock transactions during the nine month period ended October 30, 2021 are summarized as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value Per
Award

 

Non-vested awards outstanding, January 30, 2021

 

 

396,555

 

 

$

168.87

 

Awards granted

 

 

139,792

 

 

 

319.52

 

Awards vested (a)

 

 

(152,896

)

 

 

152.85

 

Awards forfeited

 

 

(16,816

)

 

 

201.01

 

Non-vested awards outstanding, October 30, 2021

 

 

366,635

 

 

 

231.52

 

 

(a)
Restricted stock awards vested during the nine month period ended October 30, 2021 had a total intrinsic value of $47.6 million. 
Performance Stock Unit Transactions

Performance stock unit transactions during the nine month period ended October 30, 2021 are summarized as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value Per
Award

 

Non-vested units outstanding, January 30, 2021

 

 

148,668

 

 

$

176.70

 

Units granted

 

 

55,294

 

 

 

321.13

 

Awards forfeited

 

 

(16,064

)

 

 

216.23

 

Non-vested units outstanding, October 30, 2021

 

 

187,898

 

 

 

215.82